banda transcan

The previous ERA-NET on translational cancer research TRANSCAN was funded by the European Commission under the FP7 from 2011 to 2014.

The network, coordinated by Italy (Ministry of Health), was comprised of  25 partners from 19 countries.

The main objective of TRANSCAN was to coordinate national and regional translational cancer research funding organisations' activities, aiming at the integration of basic, clinical and epidemiological cancer research and facilitation of coordinated, transnational cancer funding in Europe with the ultimate aim to streamline EU-wide cancer screening, early diagnosis, prognosis, treatment and care.

The specific objectives of TRANSCAN have been achieved through the implementation of interconnected activities, structured into the following six work packages:

Work Package 1 - Management and network coordination (Leader: MoH-ISS, Italy)
Work Package 2 - Survey and analysis of national cancer research funding of translational cancer research (Leader: CR-UK, United Kingdom)
Work Package 3 - Preparation of joint transnational calls (JTCs) (Leader: ISCIII, Spain)
Work Package 4 - Implementation of joint transnational calls (JTCs) (Leader: DLR, Germany)
Work Package 5 - Implementation of capacity building & training activities (Leader: INCa, France)
Work Package 6 - Monitoring of activities & network sustainability (Leader: FCT, Portugal)

In the frame of TRANSCAN, three Joint Transnational Calls were launched

JTC 2011
JTC 2012
JTC 2013


TRANSCAN News

 TRANSCAN-3 news on:
twitter logoinkedin social media logo

TRANSCAN-3   JOINT TRANSNATIONAL CALL 2022 on:
 "Novel translational approaches to tackle the challenges of hard-to-treat cancers from early diagnosis to therapy"  

is open for submission

Please visit the TRANSCAN-3 website at
https://transcan.eu/funding/calls/joint-call-jtc-2022-.kl


Other news:

The Digital Institute for Cancer Outcomes Research (DIGICORE),  is delighted to announce an innovative new training programme for early career researchers in oncology: IDEAL4RWE.
 Please register for an introductory webinar on the19th April 2022(https://lnkd.in/ez7y4kWU).
Brochure for more details: https://tinyurl.com/y7aurdtk


 The first TRANSCAN-3 call (JTC 2021) on:
"Next generation cancer immunotherapy: targeting the tumour microenvironment"
is closed for submission

International Networking Event (virtual)
on 22 April 2021 hrs 9:00 CET
will focus on the forthcoming co-funded JTC 2021 on:
"Next generation cancer immunotherapy: targeting the tumour microenvironment" 
the event is organized by TUBITAK under the “Turkey in Horizon 2020 Phase II” Technical Assistance Project
in cooperation with TRANSCAN-3

The new ERA-NET Cofund TRANSCAN-3:
 Sustained collaboration of national and regional programmes in cancer research
is funded by the European Commission under H2020  which started on 1st March 2021 and will last five years (G. A. no. 964264)

A TRANSCAN-2 brochure, highlighting key achievements, is available for download

 

Newsletters

The TRANSCAN-3 newsletters are published at: https://www.transcan.eu/

SUBSCRIBE to the newsletters
You can unsubscribe at any moment by clicking on the subscription preferences link at the bottom of a received newsletter


All the TRANSCAN-2 newsletters:

Newsletter 10, Sept.2020
Newsletter 9, Dec.2019

Newsletter 8, May 2019
Newsletter 7, Oct.2018
Newsletter 6, June 2108
Newsletter 5, March 2018
Newsletter 4, Dec. 2017
Newsletter 3, Sept. 2017
Newsletter 2, April 2017
Newsletter 1, Dec. 2016

eu flagship

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 643638.

Who's Online

We have 12 guests and no members online